Format
Items per page
Sort by

Send to:

Choose Destination

Results: 20

1.

Infant developmental outcomes following prenatal exposure to antidepressants, and maternal depressed mood and positive affect.

Hanley GE, Brain U, Oberlander TF.

Early Hum Dev. 2013 Aug;89(8):519-24. doi: 10.1016/j.earlhumdev.2012.12.012. Epub 2013 Feb 4.

PMID:
23384962
[PubMed - indexed for MEDLINE]
2.

Neurodevelopmental outcomes following prenatal exposure to serotonin reuptake inhibitor antidepressants: a "social teratogen" or moderator of developmental risk?

Hanley GE, Oberlander TF.

Birth Defects Res A Clin Mol Teratol. 2012 Aug;94(8):651-9. doi: 10.1002/bdra.23032. Epub 2012 Jun 26. Review.

PMID:
22733632
[PubMed - indexed for MEDLINE]
3.

The effect of perinatal exposures on the infant: antidepressants and depression.

Hanley GE, Oberlander TF.

Best Pract Res Clin Obstet Gynaecol. 2014 Jan;28(1):37-48. doi: 10.1016/j.bpobgyn.2013.09.001. Epub 2013 Sep 18. Review.

PMID:
24100223
[PubMed - indexed for MEDLINE]
4.

Fetal serotonin signaling: setting pathways for early childhood development and behavior.

Oberlander TF.

J Adolesc Health. 2012 Aug;51(2 Suppl):S9-16. doi: 10.1016/j.jadohealth.2012.04.009. Review.

PMID:
22794534
[PubMed - indexed for MEDLINE]
5.

Acute and long-term behavioral outcome of infants and children exposed in utero to either maternal depression or antidepressants: a review of the literature.

Suri R, Lin AS, Cohen LS, Altshuler LL.

J Clin Psychiatry. 2014 Oct;75(10):e1142-52. doi: 10.4088/JCP.13r08926. Review.

PMID:
25373125
[PubMed - indexed for MEDLINE]
6.

Neonatal signs after late in utero exposure to serotonin reuptake inhibitors: literature review and implications for clinical applications.

Moses-Kolko EL, Bogen D, Perel J, Bregar A, Uhl K, Levin B, Wisner KL.

JAMA. 2005 May 18;293(19):2372-83. Review.

PMID:
15900008
[PubMed - indexed for MEDLINE]
7.

Serotonin reuptake inhibitor-induced perinatal complications.

Gentile S.

Paediatr Drugs. 2007;9(2):97-106. Review.

PMID:
17407365
[PubMed - indexed for MEDLINE]
8.

Paediatric outcomes following intrauterine exposure to serotonin reuptake inhibitors: a systematic review.

Fenger-Grøn J, Thomsen M, Andersen KS, Nielsen RG.

Dan Med Bull. 2011 Sep;58(9):A4303. Review.

PMID:
21893008
[PubMed - indexed for MEDLINE]
9.

Prenatal exposure to antidepressants and persistent pulmonary hypertension of the newborn: systematic review and meta-analysis.

Grigoriadis S, Vonderporten EH, Mamisashvili L, Tomlinson G, Dennis CL, Koren G, Steiner M, Mousmanis P, Cheung A, Ross LE.

BMJ. 2014 Jan 14;348:f6932. doi: 10.1136/bmj.f6932. Review.

PMID:
24429387
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

Prenatal cocaine exposure, child development, and the compromising effects of cumulative risk.

Tronick EZ, Beeghly M.

Clin Perinatol. 1999 Mar;26(1):151-71. Review.

PMID:
10214547
[PubMed - indexed for MEDLINE]
11.

Linking prenatal maternal adversity to developmental outcomes in infants: the role of epigenetic pathways.

Monk C, Spicer J, Champagne FA.

Dev Psychopathol. 2012 Nov;24(4):1361-76. doi: 10.1017/S0954579412000764. Review.

PMID:
23062303
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

Serotonin hypothesis of autism: implications for selective serotonin reuptake inhibitor use during pregnancy.

Harrington RA, Lee LC, Crum RM, Zimmerman AW, Hertz-Picciotto I.

Autism Res. 2013 Jun;6(3):149-68. doi: 10.1002/aur.1288. Epub 2013 Mar 14. Review.

PMID:
23495208
[PubMed - indexed for MEDLINE]
13.

Breastfeeding and antidepressants.

Field T.

Infant Behav Dev. 2008 Sep;31(3):481-7. doi: 10.1016/j.infbeh.2007.12.004. Epub 2008 Feb 12. Review.

PMID:
18272227
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

Prenatal cannabis exposure and infant outcomes: overview of studies.

Huizink AC.

Prog Neuropsychopharmacol Biol Psychiatry. 2014 Jul 3;52:45-52. doi: 10.1016/j.pnpbp.2013.09.014. Epub 2013 Sep 27. Review.

PMID:
24075896
[PubMed - indexed for MEDLINE]
15.

Cognitive and motor development of children with and without congenital adrenal hyperplasia after early-prenatal dexamethasone.

Meyer-Bahlburg HF, Dolezal C, Baker SW, Carlson AD, Obeid JS, New MI.

J Clin Endocrinol Metab. 2004 Feb;89(2):610-4. Review.

PMID:
14764770
[PubMed - indexed for MEDLINE]
16.

Maternal use of antidepressant or anxiolytic medication during pregnancy and childhood neurodevelopmental outcomes: a systematic review.

El Marroun H, White T, Verhulst FC, Tiemeier H.

Eur Child Adolesc Psychiatry. 2014 Oct;23(10):973-92. doi: 10.1007/s00787-014-0558-3. Epub 2014 May 27. Review.

PMID:
24863148
[PubMed - indexed for MEDLINE]
17.

Practitioner review: maternal mood in pregnancy and child development--implications for child psychology and psychiatry.

O'Connor TG, Monk C, Fitelson EM.

J Child Psychol Psychiatry. 2014;55(2):99-111. doi: 10.1111/jcpp.12153. Epub 2013 Oct 16. Review.

PMID:
24127722
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

Prenatal antidepressant exposure: clinical and preclinical findings.

Bourke CH, Stowe ZN, Owens MJ.

Pharmacol Rev. 2014 Feb 24;66(2):435-65. doi: 10.1124/pr.111.005207. Print 2014. Review.

PMID:
24567054
[PubMed - indexed for MEDLINE]
Free Article
19.

Long-term outcomes of developmental exposure to fluoxetine: a review of the animal literature.

Kiryanova V, McAllister BB, Dyck RH.

Dev Neurosci. 2013;35(6):437-9. Review.

PMID:
24247012
[PubMed - indexed for MEDLINE]
Free Article
20.

Developmental psychobiology: prenatal, perinatal, and early postnatal aspects of behavioral development.

Hall WG, Oppenheim RW.

Annu Rev Psychol. 1987;38:91-128. Review. No abstract available.

PMID:
3548581
[PubMed - indexed for MEDLINE]
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk